SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?


To: Popiye who wrote (829)4/25/1998 10:17:00 PM
From: JOHN WHITE  Read Replies (1) | Respond to of 4650
 
Popiye Brad's research is very meticulous and is accurate to the best of his & our knowledge.



To: Popiye who wrote (829)4/25/1998 11:04:00 PM
From: Mark Haythorn  Respond to of 4650
 
I think Brad's assessment is right on the money.

Just keep in mind that Biomoda's technology is 'young' in that we have a LONG way to go before seeing any money from a *therapeutic* agent, if it even works. The diagnostic could be much faster.

So, keep the Biomoda deal in perspective- it is a start-up biotech venture with lots of risk. Considering the stock is abt. 20 cents per share, I think it's a great risk!

In my opinion, don't bet the farm on ADOT, but there certainly is upside potential. Heck, the stock saw 50 cents just a few weeks ago (200+% more than it is now)

-Mark



To: Popiye who wrote (829)4/25/1998 11:06:00 PM
From: Brad  Read Replies (1) | Respond to of 4650
 
Hi Popiye! I update my information periodically and share it with everyone here. I don't claim to "know it all," but I HAVE spent some time studying this stock.

I am just a normal investor and have my own money at risk. I am NOT associated with ADOT or BIOMODA at all. My information is provided simply to help people get a "jump start" on their own research.

I must add that the KEY thing that holds my interest in ADOT is BIOMODA!

I have known of Dr Geno Saccomanno's research in Lung Cancer for many years. I do not know him personally (as a friend), but I have met him and he lives in my home town back in Colorado. He is considered the world's leading pulmonary cyto-pathologist.

I have spoken with his research assistant. I had to quiz her a bit as she was reluctant to tell me anything. When I told her what I knew, she opened up a bit and I could tell she was genuinely excited about this work. She confirmed that this is definitely a "break-through technology!"

To me, the BIOMODA ownership is a "gold mine."

This section from my "overview" will acquaint others with Dr Saccomanno.

=======================================
SCIENTIFIC ADVISORY BOARD Includes Noted Leader in Lung Cancer Research: Geno Saccomanno, M.D., Ph.D. of St. Mary's Hospital and
Medical Center in Colorado.
Dr Saccomanno is considered "the world's best pulmonary
cyto-pathologist."
emphysemafoundation.org

Dr Saccomanno is one of the most highly respected lung cancer
researchers in the world.
He has been actively involved in lung cancer research for over 40
years and is most noted for his lung cancer research involving
uranium miners throughout Colorado. He works closely with the
US Dept of Justice and the US Dept of Energy.
Here are a few more sites that reflect his work.
agi.umd.edu
aacr.org
aacr.org
niehs.nih.gov
columbia.net
uchsc.edu
eml.doe.gov
ehpnet1.niehs.nih.gov
biomoda.com

Here are the bios on the Scientific Advisory Board for Biomoda:
biomoda.com
===============================================

Best wishes,
Brad